1-4 of 4
Peter L. Greenberg
Close
Sort by
Journal Articles

An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS

Clinical Trials & Observations
Maximilian Stahl, Omar Abdel-Wahab, Andrew H. Wei, Michael R. Savona, Mina L. Xu, Zhuoer Xie, Justin Taylor, Daniel Starczynowski, Guillermo F. Sanz, David A. Sallman, Valeria Santini, Gail J. Roboz, Mrinal M. Patnaik, Eric Padron, Olatoyosi Odenike, Aziz Nazha, Stephen D. Nimer, Ravindra Majeti, Richard F. Little, Steven Gore, Alan F. List, Vijay Kutchroo, Rami S. Komrokji, Tae Kon Kim, Nina Kim, Christopher S. Hourigan, Robert P. Hasserjian, Stephanie Halene, Elizabeth A. Griffiths, Peter L. Greenberg, Maria Figueroa, Pierre Fenaux, Fabio Efficace, Amy E. DeZern, Matteo G. Della Porta, Naval G. Daver, Jane E. Churpek, Hetty E. Carraway, Andrew M. Brunner, Uma Borate, John M. Bennett, Rafael Bejar, Jacqueline Boultwood, Sanam Loghavi, Jan Philipp Bewersdorf, Uwe Platzbecker, David P. Steensma, Mikkael A. Sekeres, Rena J. Buckstein, Amer M. Zeidan
Journal: Blood Advances
Blood Adv (2023) 7 (12): 2709–2714.
https://doi.org/10.1182/bloodadvances.2022008747
Published: 2023
Journal Articles

Ex vivo drug screening defines novel drug sensitivity patterns for informing personalized therapy in myeloid neoplasms

Clinical Trials & Observations
Michael A. Spinner, Alexey Aleshin, Marianne T. Santaguida, Steven A. Schaffert, James L. Zehnder, A. Scott Patterson, Christos Gekas, Diane Heiser, Peter L. Greenberg
Journal: Blood Advances
Blood Adv (2020) 4 (12): 2768–2778.
https://doi.org/10.1182/bloodadvances.2020001934
Published: 2020
Includes: Supplemental data
Journal Articles

MMP9 inhibition increases erythropoiesis in RPS14-deficient del(5q) MDS models through suppression of TGF-β pathways

Minyoung Youn, Haigen Huang, Cheng Chen, Sharon Kam, Mark C. Wilkes, Hee-Don Chae, Kunju J. Sridhar, Peter L. Greenberg, Bertil Glader, Anupama Narla, Shuo Lin, Kathleen M. Sakamoto
Journal: Blood Advances
Blood Adv (2019) 3 (18): 2751–2763.
https://doi.org/10.1182/bloodadvances.2019000537
Published: 2019
Includes: Supplemental data
Journal Articles

Molecular pathophysiology of the myelodysplastic syndromes: insights for targeted therapy

Clinical Trials & Observations
Alex Aleshin, Peter L. Greenberg
Journal: Blood Advances
Blood Adv (2018) 2 (20): 2787–2797.
https://doi.org/10.1182/bloodadvances.2018015834
Published: 2018